No Data
Glaukos Stock Down Despite NDA Submission of Epioxa to the FDA
Glaukos Insider Sold Shares Worth $1,502,800, According to a Recent SEC Filing
Insider Sale: Director at $GKOS (GKOS) Sells 10,000 Shares
Glaukos Seeks FDA Approval for Non-Invasive Keratoconus Therapy Epioxa
Express News | Glaukos Submits New Drug Application to U.S. FDA for Epioxa™
The Three-year Returns Have Been Stellar for Glaukos (NYSE:GKOS) Shareholders Despite Underlying Losses Increasing